Joober, Ridha.
Genetic, environmental and other design issues relevant for pharmacogenetics studies [electronic resource] / Ridha Joober. - London : Henry Stewart Talks, 2007. - 1 online resource (1 streaming video file (45 min.) : color, sound). - Psychopharmacogenetics : genetic factors influencing the kinetics and dynamics of psychotropic drugs, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Psychopharmacogenetics : genetic factors influencing the kinetics and dynamics of psychotropic drugs. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Definition of pharmacogenetics (PGx), pharmacokinetics and pharmacodynamics -- Modulation of PGx phenotypes -- Genetic factors play a role in determining the variability of PGx phenotypes -- Study design -- Genetic epidemiology -- Familial aggregation studies -- Twin and adoption studies -- Therapeutic response to psychotropic drugs -- Pharmaco-epidemiology and PGx phenotypes -- Animal models -- Balancing modest epidemiological evidence against biological pertinence -- Studying PGx phenotypes in relation to candidate genes -- Family-based vs. case control designs -- Observer effect -- Sampling bias -- Factors related to the subject.
Access restricted to subscribers.
Mode of access: World Wide Web.
1269 Henry Stewart Talks
Pharmacogenetics.
Psychopharmacology.
Psychotropic Drugs.
Genetic, environmental and other design issues relevant for pharmacogenetics studies [electronic resource] / Ridha Joober. - London : Henry Stewart Talks, 2007. - 1 online resource (1 streaming video file (45 min.) : color, sound). - Psychopharmacogenetics : genetic factors influencing the kinetics and dynamics of psychotropic drugs, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Psychopharmacogenetics : genetic factors influencing the kinetics and dynamics of psychotropic drugs. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Definition of pharmacogenetics (PGx), pharmacokinetics and pharmacodynamics -- Modulation of PGx phenotypes -- Genetic factors play a role in determining the variability of PGx phenotypes -- Study design -- Genetic epidemiology -- Familial aggregation studies -- Twin and adoption studies -- Therapeutic response to psychotropic drugs -- Pharmaco-epidemiology and PGx phenotypes -- Animal models -- Balancing modest epidemiological evidence against biological pertinence -- Studying PGx phenotypes in relation to candidate genes -- Family-based vs. case control designs -- Observer effect -- Sampling bias -- Factors related to the subject.
Access restricted to subscribers.
Mode of access: World Wide Web.
1269 Henry Stewart Talks
Pharmacogenetics.
Psychopharmacology.
Psychotropic Drugs.